The Gynaecological Cancer Fund is the working name for the recently formed charity, The Grace Belgravia Foundation. Our objective is to support:
- Awareness initiatives
Initially, our time and energy will be focused on a single research project. Our first target is to raise £750,000 over the next three years to fund clinical trials and research carried out by Dr Susana Banerjee and the team at The Royal Marsden. If the www.writemypaper4me.org/ book you use for comparison doesn’t have good sales numbers, your effort might flop!
DR BANERJEE’S GROUND-BREAKING RESEARCH
Dr Banerjee’s research into the use of genome therapy is critical to making life-changing treatment decisions for women. It is a personalised approach to cancer treatment that tailors drugs to each individual patient. Dr Banerjee wants to move on from the ‘one-size-fits-all’ approach that uses non-specific, largely toxic drugs. Initial work has clearly shown that tumours can be reduced and quality of life greatly improved. Dr Banerjee’s findings have also made a major impact on broader categories of cancer treatment, including breast cancer. Over the next three years she will pilot a bespoke, genome-based testing and treating approach. Her vision is that it will lead towards routine genome testing of all women with gynaecological cancers and a reduction in treatment costs.
ABOUT DR BANERJEE
Dr Susana Banerjee MBBS MA MRCP PhD is a consultant oncologist, specialising in the treatment of women with gynaecological cancers at The Royal Marsden hospital. Dr Banerjee graduated with a first-class degree from Cambridge University; completed her medical training at the Royal Free Medical School and gained a PhD from The Institute of Cancer Research, University of London. As a leader in the field she has won multiple international awards for research, lectures regularly at international conferences, has published many articles and serves on the European Society of Medical Oncology Committee.